In the context of endometrial cancer, the high expression of leptin receptors in adipose tissue may enhance leptin‐driven lipolysis, alongside the influence of cancer cells on cancer‐associated adipocytes [50]. The gene discussed is LEP; the disease is endometrial cancer.